Familial scleroderma: Nature, nurture or both?

Internal Medicine Journal

Volumn 38, Issue 4, 2008, Pages 235-242

  Englert, H ^a,c   Roberts Thomson, P J ^b   Byth, K ^a   Manolios, N ^a  

^a WESTMEAD HOSPITAL   (Australia)

^b FLINDERS MEDICAL CENTRE   (Australia)

^c NONE   (Australia)

Author keywords

Classification; Diffuse; Familial; Limited; Onset; Scleroderma

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FAMILIAL DISEASE; FEMALE; HUMAN; MALE; ONSET AGE; PRIORITY JOURNAL; RAYNAUD PHENOMENON; RISK FACTOR; SCLERODERMA;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SCLERODERMA, LOCALIZED;

EID: 41549120311     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2007.01525.x     Document Type: Article

References (29)

1. Sasaki T, Denpo K, Onon H, Nakajima H. HLA in systemic scleroderma (PSS) and familial scleroderma. J Dermatol 1991 18 : 18 24.
2. Briggs D, Black C, Welsh K. Genetic factors in scleroderma. Rheum Dis Clin North Am 1990 16 : 31 51.
3. Welsh KI, Briggs DC. Genetic and environmental factors in scleroderma. Curr Opin Rheumatol 1991 3 : 944 6.
4. Harley JB, Neas BR. Oklahoma Choctaw and systemic sclerosis: the founder effect and genetic susceptibility. Arthritis Rheum 1998 41 : 1725 8.
5. Englert HJ, Small-McMahon J, Chambers P, O'Conner H, Davis K, Manolis N et al. Familial risk estimation in systemic sclerosis. Aust NZ J Med 1999 29 : 36 41.
6. Erasmus LD. Scleroderma in gold miners on the Witwatersrand with particular reference to pulmonary manifestations. S Afr J Lab Clin Med 1957 3 : 209 31.
7. Rodnan GP, Benedek TG, Medsger TA, Cammarata RJ. The association of progressive systemic sclerosis (scleroderma) with coal miners' pneumoconiosis and other forms of silicosis. Ann Intern Med 1967 66 : 323 34.
8. Haustein U-F. Systemic sclerosis (scleroderma). In : Black CM, Myers AR, eds. New York : Gower Medical Publishing Company 1985 138 41.
9. Sluis-Cremer GK, Hassel PA, Nizdo EH, Churchill AR, Zeiss EA. Silica, silicosis and progressive systemic sclerosis. Br J Ind Med 1985 41 : 838 43.
10. Englert HJ, Small-McMahon J, Davis K, O'Connor H, Chambers P, Brooks P. Male systemic sclerosis and occupational silica exposure-a population-based study. Aust NZ J Med 2000 30 : 215 20.
11. Walder B. Solvents and scleroderma. Lancet 1965 2 : 436 7.
12. Lockey JE, Kelly CR, Cannon GW, Colby TV, Aldrich V, Livingston GK. Progressive systemic sclerosis associated with exposure to trichloroethylene. J Occup Med 1987 29 : 493 6.
13. Nietert PJ, Sutherland SE, Silver RM, Pandey JP, Knapp RG, Hoel DG et al. Is occupational organic solvent exposure a risk factor for scleroderma? Arthritis Rheum 1998 41 : 1111 18.
14. Silman AJ, Hicklin AJ, Black C. Geographical clustering of scleroderma in south and west London. Br J Rheumatol 1990 29 : 92 6.
15. Valesini G, Litta A, Bonavita MS, Luan FL, Purpura M, Mariani M et al. Geographical clustering of scleroderma in a rural area in the province of Rome. Clin Exp Rheumatol 1994 11 : 41 7.
16. Thompson AE, Pope JE. Increased prevalence of scleroderma in southwestern Ontario: a cluster analysis. J Rheumatol 2002 29 : 1867 73.
17. Englert HJ, Joyner E, Bade R, Thompson M, Morris D, Chambers P et al. Systemic scleroderma - a spatiotemporal clustering. Intern Med J 2005 35 : 228 33.
18. Feghali-Bostwick C, Medsger TA Jr., Wright TM. Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies. Arthritis Rheum 2003 48 : 1956 63.
19. Stephens CO, Briggs DC, Whyte J, Artlett CM, Scherbrakov AB, Olsen N et al. Familial scleroderma-evidence for environmental versus genetic trigger. Br J Rheumatol 1994 33 : 1131 5.
20. Chandran G, Smith M, Ahern MJ, Roberts-Thomson PJ. A study of scleroderma in South Australia: prevalence, subset characteristics and nailfold capillaroscopy. Aust NZ J Med 1995 25 : 688 94.
21. Englert H, Small-McMahon J, Davis K, O'Connor H, Chambers P, Brooks P. Systemic sclerosis prevalence and mortality in Sydney 1974-88. Aust NZ J Med 1999 29 : 42 50.
22. Englert HJ, Dracos G, Dunckley H, York J, Richards G, Penny R et al. Systemic sclerosis in DRw52-positive silica-exposed males: a case report. Ann Acad Med Singapore 1998 27 : 279 84.
23. Alamanos Y, Tsifetaki N, Voulgari PV, Siozos C, Tsamandouraki K, Alexiou GA et al. Epidemiology of systemic sclerosis in northwestern Greece 1981 to 2002. Semin Arthritis Rheum 2005 34 : 714 20.
24. Roberts-Thomson PJ, Jones M, Walker JG, Macfarlane JG, Smith MD, Ahern MJ. Stochastic processes in the causation of rheumatic disease. J Rheumatol 2002 29 : 2628 34.
25. Chatterjee S, Dombi GW, Severson RK, Mayes MD. Risk of malignancy in scleroderma: a population-based cohort study. Arthritis Rheum 2005 52 : 2415 24.
26. Medsger TA Jr., Masi AT. The epidemiology of systemic sclerosis (scleroderma) among male US veterans. J Chronic Dis 1978 31 : 73 85.
27. Medsger TA Jr., Masi AT. Survival with scleroderma. II A life table analysis of clinical and demographic factors in 358 male US veteran patients. J Chronic Dis 1973 26 : 647 60.
28. Hirschl M, Hirschl K, Lenz M, Katzenschlager R, Hutter HP, Kundi M. Transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon identified by diagnosis of an associated disease. Results of ten years of prospective surveillance. Arthritis Rheum 2006 54 : 1974 81.
29. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and therapeutic Criteria Committee. Arthritis Rheum 1980 23 : 581 90.